PSK9 PRIOR AUTHORIZATION FOR TOPICAL PSORIASIS TREATMENTS- IS IT COST-BENEFICIAL FOR MANAGED CARE?
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65615-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65615-X/fulltext
Section Title :
Section Order :
775
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65615-X&doi=10.1016/S1098-3015(10)65615-X